Best BioTech Nation Podcasts (2025)

1
When Your Immune System Overreacts...Prof. Dr. Niels Riedemann, Co-Founder & CEO, InflaRx 21:52

Play Pause

5d ago21:52

21:52

This week on BioTech Nation, we explore what happens when your immune system overreacts. Professor Niels Riedemann, CEO of InflaRx, explains how the body’s defense system can sometimes cause more harm than good, leading to serious conditions like rheumatoid arthritis, severe COVID-19, and lung failure. Learn how InflaRx is developing treatments to …

1
#94: Nvidia’s Red Flags, NeoCloud Bubble & the Quiet Quant Crash 38:36

20h ago38:36

38:36

0:00 – Intro0:42 – Nvidia earnings: strong growth but odd details2:10 – Circular Nvidia deals: inventories, AR and “not-real” revenue4:40 – Retail mania: quantum computing, nuclear & Aussie drone stocks7:05 – When the music stops: 60–80% drawdowns in retail favourites9:05 – NeoClouds explained: ex-Bitcoin miners turned AI GPU landlords12:05 – Hyper…

1
What the Data Says About Founder-Led Outperformance (w/ Jack Ablin of Cresset Asset Management) | #611 44:39

3d ago44:39

44:39

Today’s guest is Jack Ablin, CIO at Cresset Asset Management, which manages over $70 billion AUM. Jack was RIA Intel’s “CIO of the Year” for 2022 and was previously the CIO at BMO for 17 years. In today’s episode, Jack walks through the ins and outs of investing in founder-led companies and what has led them to historically outperform. He also expl…

1
Restoring Lost Crops with Professor David Shields 1:49:57

20h ago1:49:57

1:49:57

Professor David Shields is most often known for his work restoring Carolina Golden Rice to prominence in his native South Carolina, but this conversation goes further to explore parallel projects returning a wide range of preindustrial crops to the local food system. We also explore the culture impact of food, and its essential role as a touchstone…

1
#95 Year-End Market: AI CapEx, Nvidia, Neo-Clouds & 2026 Setup | Frazis Capital Podcast 43:12

6d ago43:12

43:12

Why markets look “fine” but small caps are quietly crashing The brutal 50 - 60% wipeouts in quantum, nuclear & neo-cloud stocks How 2025 became a one-way market dominated by AI & semiconductors AI CapEx, rate expectations, and why headlines are driving everything OpenAI vs Google Gemini vs Claude, who’s actually winning the AI race? The uncomfortab…

1
David McWilliams on The Story of Money—and Why It Matters for Markets | #610 54:21

6d ago54:21

54:21

Today’s guest is David McWilliams, an economist, podcast host and author. David worked at the Central Bank of Ireland, UBS and BNP Paribas and is the founder of the Kilkenomics Festival, a unique blend of economics and stand-up comedy. His book is called The History of Money: A Story of Humanity, which is my favorite book from 2025. In today’s epis…

1
Deals Outlook 2026: What’s ahead for pharma and life sciences 11:14

6d ago11:14

11:14

Tune in as Glenn Hunzinger and Roel van den Akker share their outlook for pharmaceutical and life sciences dealmaking in 2026. They discuss improving market conditions, innovation driven growth, and how upcoming loss of exclusivity is shaping deal strategy. Discussion highlights: Strong innovation, healthy balance sheets, and improving capital mark…

1
Deals Outlook 2026: What’s ahead for health services 8:57

6d ago8:57

8:57

Join Glenn Hunzinger and Dan Farrell as they discuss why 2026 could mark a rebound year for health services dealmaking—driven by higher-quality assets, improving market conditions, and the growing role of technology and AI. They explore how investors are rethinking value creation, from tech-enabled care models to carve-outs and IPOs. Discussion hig…

1
Resource Limits with the Honest Sorcerer 1:45:26

8d ago1:45:26

1:45:26

The Honest Sorcerer is an engineer from Eastern Europe with a passion for studying the resource limits squeezing our global industrial economy. We talk about the intersections between advancing technology, eroding resources, deflating demographics and scrambling politics along with many other topics usually considered in isolation. The discussion p…

1
Renewed Potential: Reviving an ALS Drug...Dr. Ari Azhir, Founder & CEO, Neuvivo 17:47

11d ago17:47

17:47

This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a crucial mistake in the trial data. Now with new insights an…

1
What It Takes to Launch and Scale a Supplement Brand with James Klein 48:03

9d ago48:03

48:03

This week, host Aaron sits down with James Klein, a true veteran of the supplement industry who’s been shaping the space for over 25 years. From the early days of garage operations and bodybuilder-backed brands, to today's landscape dominated by eCommerce giants and stringent compliance requirements, James Klein shares a candid insider perspective …

1
BlackRock’s Rick Rieder - Rethinking Risk Into 2026 | #609 45:49

13d ago45:49

45:49

Today’s guest is Rick Rieder. Rick oversees more than $2 trillion in assets as the Chief Investment Officer of Global Fixed Income at BlackRock. He also heads the Fundamental Fixed Income business and the Global Allocation Investment Team. In today’s episode, Rick discusses the current state of the markets, focusing on year-end dynamics, free cash …

1
Bruce Steele 1:32:11

16d ago1:32:11

1:32:11

Bruce Steele works with resilient, low input staple crops (including oaks for flour) and breeds heritage mangalitsa pigs in Southern California. Check out Bruce's substack: https://steeleb.substack.com Learn more about Bruce's farm: https://www.winfieldfarm.us Read Shane's weekly blog for free, or support his work with a paid subscription to get ac…

1
Preventing Pressure Injuries: Detecting the Invisible Signs, Martin Burns, CEO Bruin Biometrics 20:22

16d ago20:22

20:22

This week on BioTech Nation, Bruin Biometrics CEO Martin Burns talks about a new diagnostic tool being used to detect and prevent potentially fatal bedsores in their earliest stages.By Moira Gunn

1
Biotech or Supplement Brand? The Strategic Playbook Behind Seed Health’s Massive Growth 52:18

16d ago52:18

52:18

In this episode, Aaron and Nathan dive deep into the fascinating world of supplements, spotlighting a true disruptor in the probiotic space: Seed. Known for its research-driven approach, Seed has transformed a crowded wellness category by prioritizing science over hype, building its brand on education and clinical validation rather than marketing g…

1
What the Wealthiest Do Differently—And What They Get Wrong (w/ Nick Maggiulli) | 608 48:51

24d ago48:51

48:51

Today’s guest is Nick Maggiulli. Nick is the COO for Ritholtz Wealth Management. He writes over at Of Dollars at Data and is the author of two books: Just Keep Buying and The Wealth Ladder. In today’s episode, Nick discusses the parallels between financialand medical advice, the differences in asset ownership across wealth levels,and the importance…

1
Are we moving from Dr. Google to Dr. ChatGPT??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 7:28

21d ago7:28

7:28

For years, we've all turned to Google to self-diagnose every cough, rash, and weird pain. Dr. Daniel Kraft says the shift is happening, from Dr. Google to Dr. ChatGPT.By Moira Gunn

1
Archdruid John Michael Greer 2:12:18

24d ago2:12:18

2:12:18

John Michael Greer is a historian of religion, the occult, and every aspect of history that typical historians overlook. In this conversation we explore the cultural impact of industrialisation and deindustrialization, and the many ways the future will be weirder and more wonderful than expected. Read John's weekly blog posts: https://www.ecosophia…

1
Structural Shifts, Policy Changes, and Market Innovations - With Emily Evans 53:11

27d ago53:11

53:11

In this episode of the Healthcare Nation Podcast, the focus is on the major shifts in U.S. healthcare, touching on policy, payers, and the delivery system. Joined by Emily Evans, Managing Director of Healthcare Policy at Hedgeye Risk Management, LLC, the discussion spans a wide array of topics including the pivotal role of direct-to-consumer pharma…

1
Connecting the Data that Changes Medicine, Dr. Lincoln Nadauld, President & CEO, Culmination Bio 18:27

1M ago18:27

18:27

This week on Biotech Nation, Dr. Lincoln Nadauld shares how Culmination Bio is using 9 million preserved tissue samples and decades of patient data to improve how we understand and treat diseases. From discovering patterns in cancer treatments to exploring breakthroughs in heart and autoimmune diseases, this unique approach is changing medicine.…

1
Mandy from Incredible Vegetables 1:17:43

1M ago1:17:43

1:17:43

Mandy operates a fantastic nursery in England specialising in a mind blowing diversity of perennial vegetables. Shane interviews her about her collecting and breeding projects, the challenges of running a commercial nursery, the advantages of buying rural land as a collective and loads of other topics. Learn more about Mandy's nursery : https://inc…

1
How Chad Janis Built Gruns Into a $100M Supplement Brand 48:43

1M ago48:43

48:43

In this episode, hosts Nathan and Aaron dive deep into the rise of Gruns—the supplement brand shaking up the greens category with their innovative gummy format. You'll hear how founder Chad Janis blended his experience in venture capital with cutting-edge supply chain know-how to transform a simple insight (everyone prefers gummies over powders or …

1
328 | Atomic Ambition: Inside the Texas Nuclear Model & What Kentucky Can Learn w/ Will Howard of Elementl 45:54

1M ago45:54

45:54

In February 2021, Winter Storm Uri plunged Texas into darkness, exposing the fragility of the modern American grid. For Will Howard, it was a call to action. In this episode, Will joins us to discuss his journey from data science to the forefront of the nuclear renaissance as a Project Developer for Elementl Power. He explains how Elementl is pione…

1
AQR’s Antti Ilmanen – US Exceptionalism: Growth Story or Valuation Trap? | #607 1:03:58

1M ago1:03:58

1:03:58

Today’s guest is Antti Ilmanen, Global Co-head of the Portfolio Solutions Group at AQR Capital Management. In today’s episode, Antti discusses the complexities of investment returns, the importance of understanding both objective and subjective expectations, and the dangers of relying on past performance as a guide for future investments. We explor…

1
Amateur Plant Biotech with Sebastian Coccioba 2:27:55

1M ago2:27:55

2:27:55

Shane talks to Sebastian Coccioba about his obsession with plant biotechnology, and how his determination to build his own home laboratory (including a gun that shoots genes into plants) paid off. Also includes a survey of all the techniques an independent scientist could consider mastering. Read more of Sebastian's work at his open lab book : http…

1
Correcting Gene-based Frontotemporal Dementia, Lisa Deschamps, CEO Aviado Bio 14:41

1M ago14:41

14:41

What if we could fix the gene that causes dementia? In this episode, Aviado Bio CEO Lisa Deschamps tells us how her team is working to correct the gene driving many cases of frontotemporal dementia.By Moira Gunn

1
Simon Michaux 2:09:50

1M ago2:09:50

2:09:50

Shane grills Simon Michaux on the key resource limits preventing the promised renewable energy transition and his comprehensive plans to develop a thorium powered alternative. Read more about Simon's work at: The complex systems limits threatening industrial civilisation: https://www.simonmichaux.com The plan to build an alternative civilisation: h…

1
Tuning your own DNA?? Dr. Derek Jantz, Chief Scientific Officer, Tune Therapeutics 17:38

1M ago17:38

17:38

What if you could tune your DNA to fix any mistakes? Dr. Derek Jantz from Tune Therapeutics talks about tuning DNA, not just with humans, but stopping the Hepatitis B virus in its tracks.By Moira Gunn

1
Ecommerce Lessons from Bloom Nutrition’s Rise to $200 Million 54:20

1M ago54:20

54:20

Aaron and Nathan reveal how Bloom Nutrition went from a niche pre-workout brand founded by Mari Llewellyn and Greg LaVacchia to Amazon’s best-selling greens powder, all by tapping into untapped audiences and making strategic moves that AG1 missed. You’ll hear how Bloom leveraged social media influence, taste innovation, and multi-channel growth to …

1
The Biotech Rebuild: Finding Alpha After the Drawdown with Chris Clark | #606 1:50:11

2M ago1:50:11

1:50:11

Today’s guest is Chris Clark. Chris was a biotech PM for 10 years at RS Investments, managing $4.5 billion. In today’s episode, Chris discusses the complexities of the biotech sector, which has suffered a dramatic drawdown the past few years. He begins by explaining how biotech works, why it’s such a unique sector, and what has kept investors and c…

1
Healthcare Under Siege: Government Shutdown and Its Dire Consequences 29:51

2M ago29:51

29:51

In this episode of the Healthcare Nation Podcast, host Rick looks at the ongoing healthcare crisis aggravated by the looming expiration of ACA premium tax credits and the unprecedented government shutdown. The discussion, featuring producer Joe Woolworth, covers the significant impact on healthcare coverage, potential premium spikes, and broader ec…

1
327 | Modernizing the Bourbon Barrel Market: Chris Wiedmar of Hogshead 1:05:29

2M ago1:05:29

1:05:29

A new digital marketplace is modernizing how bourbon barrels are bought, sold, and valued across Kentucky’s signature industry. In this episode, Hogshead co-founder and CEO Chris Wiedmar joins us to share how his company is bringing transparency and technology to the bourbon supply chain - transforming a relationship-driven trade into a data-driven…

1
Vanguard’s Joe Davis on AI vs. The National Debt: The Tug-of-War To Decide America’s Future | #605 1:02:05

2M ago1:02:05

1:02:05

Today’s guest is Joe Davis, Vanguard’s Global Chief Economist and Global Head of Vanguard’s Investment Strategy Group. His latest research on megatrends is covered in his book, Coming Into View: How AI and Other Megatrends Will Shape Your Investments. In today’s episode, Joe explains why the coming decade for the U.S. economy will be shaped by a tu…

1
A New Way to Treat Wounds?? Dr. Ned Swanson, Co-Founder, President & Chief Medical Officer, Polarity Bio 15:02

2M ago15:02

15:02

Imagine a world where the toughest wounds heal twice as fast, and patients get their lives back sooner than anyone thought possible. Dr. Ned Swanson, the President and Chief Medical Officer of Polarity Bio, tells us about their approach to healing serious, hard-to-treat skin wounds. In early trials, it's twice as effective as the current treatment …

1
Thomas Picard 1:41:07

2M ago1:41:07

1:41:07

Thomas Picard is a landrace cucurbit breeder from France who works with melons, watermelon, pumpkin and kiwano. You can read more about his work at the Going to Seed forum- https://goingtoseed.discourse.group/u/thomaspicard/summary Links to the Going to Seed conference will be added once they are available. Follow Shane's work at his Substack blog:…

1
Kathryn Kaminski - Don’t Fire Your Diversifier | #604 40:15

2M ago40:15

40:15

Today’s guest is Kathryn Kaminski, Chief Research Strategist at AlphaSimplex, where she’s also the co-portfolio manager for the firm’s Managed Futures Strategy and Global Alternatives Strategy. She also co-authored the book Trend Following with Managed Futures: The Search for Crisis Alpha. In today’s episode, Meb and Katy discuss the tough year for…

1
Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma 17:12

2M ago17:12

17:12

40% of all rheumatoid arthritis patients do not respond to any of the current drugs. Rob Armstrong, CEO of Artax Biopharma, aims to bring new hope for those patients who've been left without effective treatment options.By Moira Gunn

1
Ghost Lifestyle: From Warheads Pre-Workout to Billion-Dollar Acquisition by Keurig Dr. Pepper 51:56

2M ago51:56

51:56

From pioneering candy-flavored protein and pre-workout supplements through collaborations with household names like Warheads and Mondelez, to expanding into energy drinks, cereals, and snacks, Ghost has become more than just a supplement company—it’s a lifestyle brand that captures the spirit of an entire community.…

1
Inside The $200 Billion World of Gaming with Peter Levin (Griffin Gaming Partners) | #603 1:04:25

2M ago1:04:25

1:04:25

Today’s guest is Peter Levin, co-founder of Griffin Gaming Partners, the largest singularly focused gaming investment vehicle in the world. Peter was previously the CEO and co-founder of Nerdist Industries, which was acquired by Legendary Entertainment. He began his career at CAA, had a stint at Disney, sold a company to UFC, and was also an early …

1
326 | Bourbon Meets Biotech: How Brandon Corace and Meridian Biotech Turn Stillage into Sustainable Products 38:31

2M ago38:31

38:31

A $40 million partnership with Buffalo Trace is giving new life to one of bourbon’s biggest byproducts: stillage.In this episode, Meridian Biotech founder Brandon Corace joins us to share how his company is transforming distillery waste into sustainable products that fuel industries like aquaculture, pet food, and fertilizer. From winning a “revers…

1
Mebisode: When to Sell 16:23

2M ago16:23

16:23

In today’s Mebisode, Meb reads his latest paper, “When to Sell?” ----- Follow Meb on⁠ ⁠⁠X⁠,⁠ ⁠⁠LinkedIn⁠ and⁠ ⁠⁠YouTube⁠ For detailed show notes, click ⁠here⁠ To learn more about our funds and follow us, subscribe to our ⁠mailing list⁠ or visit us at⁠ ⁠⁠cambriainvestments.com⁠ ----- Follow The Idea Farm: ⁠X⁠ | ⁠LinkedIn⁠ | ⁠Instagram⁠ | ⁠TikTok⁠ --…